Financials

  • Market Capitalization 706.54 M
  • Employee 106
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.91
Rapporto prezzo/fatturato
34.38

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2678
AURA
Aura Biosciences, Inc. - Common Stock
7.00 USD0.00%-0.43%+8.02%+2.94%723.71 M USD
2680
CADL
Candel Therapeutics, Inc. - Common Stock
9.87 USD+2.39%+2.49%+13.45%+51.85%723.18 M USD
2727
MNPR
Monopar Therapeutics Inc. - Common Stock
99.79 USD-3.43%+6.31%+64.94%+82.70%668.50 M USD
2737
TECX
Tectonic Therapeutic, Inc. - Common Stock
34.81 USD+1.37%-4.13%+13.54%+102.97%656.84 M USD